MGMT-Methylated Glioblastoma

general

A glioblastoma characterized by the absence of DNA methylation in the promoter region of the MGMT gene. It is associated with a poor outcome.

23

Centers

1

Active Trials

Cancer Funding

Specific Cancer Types(1)

NameCenters
Recurrent MGMT-Methylated Glioblastoma23

Top Centers for MGMT-Methylated Glioblastoma(23)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Clinical
High-Volume Research Center
73.7
2
NCI Comprehensive
51.2
3
NCI Comprehensive
51.2
4
NCI Comprehensive
51.2
551.2
6
NCI Comprehensive
51.2
751.2
851.2
9
NCI Comprehensive
51.2
10
NCI Comprehensive
51.2
11
NCI Comprehensive
51.2
12
NCI Comprehensive
51.2
13
NCI Comprehensive
51.2
14
NCI Comprehensive
51.2
15
NCI Comprehensive
51.2
16
NCI Comprehensive
51.2
17
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
51.2
1851.2
1951.2
2051.2
2151.2
2251.2
2351.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →